Maternal physiological adaptations, such as changes to the hypothalamic-pituitary-adrenal (HPA) axis, are central to pregnancy success. Circadian variation of the HPA axis is dependent on clock gene rhythms in the hypothalamus, but it is not known whether pregnancy-induced changes in maternal glucocorticoid levels are mediated via this central clock. We hypothesized that hypothalamic expression of clock genes changes across mouse pregnancy and this is linked to altered HPA activity. The anterior hypothalamus and maternal plasma were collected from C57Bl/6J mice prior to pregnancy and on days 6, 10, 14 and 18 of gestation (termZd19), across a 24-h period (0800, 1200, 1600, 2000, 0000, 0400 h). Hypothalamic expression of clock genes and Crh was determined by qPCR, plasma ACTH concentration measured by Milliplex assay and plasma corticosterone concentration by LC-MS/MS. Expression of all clock genes varied markedly across gestation, most notably at mid-gestation when levels of each gene were elevated. The pregnancy-induced increase in maternal corticosterone levels (by up to 14-fold on day 14) was not accompanied by a parallel shift in plasma ACTH (28% lower on day 14 compared with non-pregnant levels). Moreover, while circadian rhythmicity in corticosterone was maintained up to day 14 of gestation, this was effectively lost by day 18. Overall, our data show that the central circadian clock undergoes marked adaptations throughout mouse pregnancy, changes that are likely to contribute to maternal physiological adaptations. Importantly, however, neither hypothalamic clock genes nor plasma ACTH levels appear to drive the marked increase in maternal corticosterone after mid-gestation.
Introduction
Maternal physiological adaptations are central to pregnancy success, balancing fetal and placental demands with the maintenance of maternal homeostasis. Among these maternal adaptations, enhanced activity of the hypothalamic-pituitary-adrenal (HPA) axis after midgestation leads to increased glucocorticoid levels (Patrick (CRH) released from the paraventricular nucleus (PVN), which stimulates pituitary secretion of adrenocorticotropic hormone (ACTH). ACTH, in turn, stimulates adrenocortical secretion of glucocorticoids (cortisol in humans and corticosterone in rodents), which exert negative feedback effects at the hypothalamus and pituitary (Spiga et al. 2014) . In pregnancy, the placenta may also provide direct trophic support to stimulate adrenal glucocorticoid secretion (Waddell 1993 , Waddell & Burton 1993 ).
An additional feature of HPA axis function is its robust circadian variation, driven in part by the rhythmic expression of clock genes in the suprachiasmatic nucleus (SCN) (Nader et al. 2010) . These clock genes (Bmal1/Arntl, Clock, Per1, Per2, Cry1 and Cry2) form a molecular network of transcriptional-translational loops to drive their own rhythmic expression and that of downstream targets including CRH (via efferent projections from the SCN to the PVN) (Nader et al. 2010) . In the core oscillatory loop, a CLOCK-BMAL1 protein heterodimer activates the transcription of Per and Cry genes. This is followed several hours later by an accumulation of PER and CRY proteins, which form complexes in the cytoplasm. These complexes translocate to the nucleus where they associate with the CLOCK-BMAL1 heterodimer and thereby inhibit the transcription of Per and Cry genes. The resultant fall in the expression of PER and CRY removes their negative feedback and the cycle is reinitiated. An accessory loop involves two transcription factors, Rev-erba and Rora, which have opposite effects on Bmal1 transcription (inhibitory and stimulatory respectively) (Hastings et al. 2007) .
In addition to this central clock, circadian variation in physiology is mediated via similar clock gene networks in key metabolic tissues, referred to as 'peripheral clocks'. The circadian rhythm of circulating glucocorticoids (generated via the HPA axis) provides a key coordination link between the central SCN clock and these peripheral clocks (Hastings et al. 2007) , and as such plays a crucial role in overall metabolic homeostasis. Accordingly, changes in clock gene networks likely mediate maternal physiological adaptations to pregnancy. One previous report has shown that peak PER2 expression in the SCN was phase advanced by 4-h on day 6 of gestation in the rat (Schrader et al. 2010) . Whether pregnancy also alters the expression of other clock genes, or whether such changes influence downstream physiology including the HPA axis, is unknown. Such changes may have important implications for pregnancy success, since circadian disruption is known to adversely affect fetal growth and developmental programming outcomes (Varcoe et al. 2011) . Therefore, in this study, we tested the hypothesis that hypothalamic expression of clock genes changes with the onset and progression of pregnancy, and that these changes are linked to altered HPA activity. Hypothalamic expression of clock genes and Crh and plasma ACTH and corticosterone levels was measured at six time points across the circadian day in the non-pregnant female mouse and on days 6, 10, 14 and 18 of mouse pregnancy.
Materials and methods

Animals
Nulliparous C57Bl/6J mice (6-9 weeks old) were supplied by the Animal Resources Centre (Murdoch, Australia). All procedures involving the use of animals were conducted after approval by the Animal Ethics Committee of the University of Western Australia (AEC no. RA/3/100/1070). Mice were maintained in two environmentally controlled rooms, with food and water supplied ad libitum. In one room, mice were exposed to a normal 12 h light:12 h darkness cycle (lights on at 0700 h); in the other room, the light cycle was reversed (lights on for 12h from 1900 h). Between 0700 and 1900 h, these mice were exposed to a constant red light (36 W, 620 nm). Preliminary studies showed no effect of exposure to red light on clock gene expression (unpublished observations). Both groups of animals were allowed to acclimatize to their respective light cycle for 2 weeks before any experimental procedures were conducted. Lights on at 0700 h (or 1900 h in the reverse-light room) was classified as a new day and as zeitgeber time (ZT)0, and sampling times were defined relative to ZT0. Female mice were mated overnight, and pregnancy was confirmed by visualization of a mucous plug the following morning (designated day 1 of pregnancy). In a separate group of non-pregnant mice, cycle stage was monitored for a minimum of three full estrous cycles by vaginal lavage (between ZT6 and ZT13) by the protocol of Caligioni (2009) . Animals with irregular cycles were excluded.
Tissue collection
Tissues and plasma were collected from mice under isoflurane/nitrous oxide anesthesia (0.2:0.8) at 4 h intervals commencing at ZT1 on either diestrus I of the cycle or day 6, 10, 14 or 18 of pregnancy (termZday 19). For collection of tissues in the dark phase, mice were anesthetized under red light and then covered with a lightproof hood before collection of tissues under white light. A blood sample was collected from all mice under anesthesia by cardiac puncture (into an EDTA tube), and the whole brain was collected and frozen on crushed dry ice. Maternal blood was centrifuged and plasma and the brain stored at K80 8C.
RNA sample preparation
Dissection of the anterior hypothalamus was carried out on dry ice, according to the protocol of Quennell et al. (2011) . Total RNA was extracted from the anterior hypothalamus using QIAzol (Qiagen), according to the manufacturer's instructions. RNA was quantified using the Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA) at 260 nm, before 1 mg of total RNA was reverse transcribed at 42 8C for 110 min by Mouse Moloney leukemia virus reverse transcriptase with random hexamers (Promega). The resultant cDNAs were purified using an ultra-clean PCR spin kit (MoBio Laboratories, Inc., Carlsbad, CA, USA), according to the manufacturer's instructions.
Real-time PCR
Analyses of mRNA expression levels for Clock, Arntl (which encodes for Bmal1), Per1, Per2, Cry1, Cry2, Nr1d1 (which encodes for Rev-erba), Rora, Crh and the reference genes succinate dehydrogenase subunit A (Sdha), hypoxanthineguanine phosphoribosyltransferase (Hprt) and beta actin (Actb) were performed by real-time PCR on the Rotorgene 6000 system (Corbett Research, Sydney, Australia). Primer pairs for all these genes (see Table 1 ) were designed using Primer-BLAST (http://www.ncbi.nlm.nih.gov). All primer pairs were designed to span introns to prevent amplification of products from genomic DNA. The resulting amplicons were separated on 1.5% agarose gel containing ethidium bromide and sequenced to confirm specificity. Standard curves were created with tenfold serial dilutions of gel-extracted (QIAEXII: Qiagen) PCR products and using the Rotorgene 6000 software. All samples were normalized against Sdha, Hprt and Actb using the GeNorm algorithm (Vandesompele et al. 2002) .
Measurement of plasma corticosterone and 11-dehydrocorticosterone
Plasma corticosterone and 11-dehydrocorticosterone (11-DHC) concentrations were analyzed using liquid chromatography tandem mass spectrometry (LC-MS/MS). The internal standard (IS) for both metabolites was cortisol d4. Briefly, 50 ml of IS (50 ng/ml) were added to 50 ml of plasma or standard and subsequently vortexed in a glass The mobile phase flow rate was 0.2 ml/min through both columns, and molecules were 'heart cut' from column 1 to column 2 within a 1-2 min time window. The instrument was operated in positive ionization mode. Assay precision was assessed during each batch by spiking EDTA plasma with compounds of interest, which were then used as quality controls. Intra-and inter-assay coefficients of variation (CV) for corticosterone were 1.4% and 3.2% respectively, and for 11-DHC were 9.7 and 17.5%.
Measurement of plasma ACTH
Plasma ACTH concentrations were measured using a Milliplex Map assay kit (Cat#MADKMAG-49K; Merck Millipore, MA, USA). Samples were centrifuged at 13 000 g for 5 min prior to analysis. The assay was performed according to the manufacturer's instructions.
Plates were read using a MAGPIX plate reader and analyzed using xPONENT Software (Merck Millipore). Intra-and inter-assay CV for ACTH were 3.9 and 7.4% respectively. Values are expressed as pg/ml.
Statistical analysis
All data are expressed as meanGS.E.M., with 6-8 mice per ZT on each day of pregnancy. Where data were not normally distributed (based on D'Agostino and Pearson omnibus normality test), values were log transformed prior to statistical analysis. Two-way ANOVA was used to compare hypothalamic clock gene expression in nonpregnant and pregnant mice (with time of day and pregnancy stage as factors). When a significant interaction was observed, time-of-day variation within each day was assessed by one-way ANOVA. Circadian rhythms were assessed by cosinor analysis using a nonlinear regression model (Genstat Version 9, VSN International Ltd, Hemel Hempstead, UK). The analysis generated the following rhythm descriptors: mesor (circadian rhythm-adjusted mean), amplitude, acrophase (time of the peak of a rhythm) and cosinor r 2 .
One-way ANOVA (GraphPad Prism 6.0, San Diego, CA, USA) was used to determine whether each of these cosinor descriptors varied with stage of pregnancy. For all ANOVAs, where the F test was significant (P!0.05), post hoc LSD tests were used for pairwise comparisons. Relationships among corticosterone, clock genes and ACTH were assessed by linear regression analysis (GraphPad Prism 6.0). For all results, differences attributable to time of day and day of pregnancy assessed by ANOVA are presented first. Where there is a significant effect of time, subsequent cosinor analyses are presented to determine the impact of day of pregnancy on circadian characteristics.
Results
Hypothalamic clock gene expression
Hypothalamic expression of all clock genes, with the exception of Rora, varied with time of day (P!0.001, ANOVA) and stage of pregnancy (P!0.001; Figs 1 and 2). Significant interactions between time of day and stage of pregnancy were evident for Bmal1 (P!0.001), Cry1 (P!0.001) and Rev-erba (P!0.05), indicating that pregnancy influenced the circadian expression of these clock genes.
Cosinor analysis revealed highly significant circadian variation for hypothalamic expression of all clock genes, again with the exception of Rora (see Table 2 for r 2 and P values). The resultant circadian characteristics (mesor, amplitude and acrophase) for clock gene expression across pregnancy are presented in Table 3 . A common feature observed among all the clock genes was elevated overall expression (i.e. mesor increased by up to 1.5-fold) by day 10 of pregnancy (Figs 1 and 2), consistent with the ANOVA data. The overall expression of Bmal1, Per2 and Rev-erba remained elevated beyond mid-pregnancy, whereas mesor levels for Clock, Cry1 and Cry2 fell by day 14 before increasing again near term (day 18). Interestingly, the amplitude of the Rev-erba profile had increased by day 10 but then returned to pre-pregnancy levels by day 18, whereas amplitudes remained unchanged across pregnancy for all the other clock genes (Fig. 2) . Finally, hypothalamic expression of Per1 fell slightly with the onset and progression of pregnancy apart from a transient rise on day 10. 
Day 10 Day 14 Day 18
Non-pregnant Z T 1 Z T 5 Z T 9 Z T 1 3 Z T 1 7 Z T 2 1 Day 6 D a y 10 Day 14 Day 18 For the majority of the clock genes, the time of peak expression (acrophase) showed little change across pregnancy (Figs 1 and 2) . The key exceptions were a 3-h phase advance for Bmal1 between days 14 and 18 (P!0.05) and a delay in the acrophase of Rev-erba, which occurred later in the day with the progression of pregnancy, shifting from approximately ZT8 in non-pregnant mice to ZT11 by day 18 of pregnancy (P!0.05).
Hypothalamic Crh expression
Surprisingly, Crh expression in the hypothalamus showed only a trend for variation with time of day (PZ0.056, ANOVA) but did vary markedly with stage of pregnancy (P!0.001; Fig. 3A) . Post hoc analysis demonstrated a clear peak in the overall expression of Crh on day 10 of pregnancy followed by a decline to non-pregnant levels on days 14 and 18. Consistent with the absence of significant time-of-day variation (by ANOVA), cosinor analysis of Crh expression showed no significant rhythmic variation at any stage (see Table 4 for r 2 and P values).
Plasma ACTH
Plasma ACTH levels varied significantly with time of day (P!0.05, ANOVA) and stage of pregnancy (P!0.0001), Relevant P values are shown in parentheses unless non-significant (NS). 
Figure 3
Hypothalamic expression of (A) Crh and plasma concentrations of (B) ACTH (pg/ml), (C) corticosterone (ng/ml) and (D) 11-DHC (ng/ml) at ZT1, ZT5, ZT9, ZT13, ZT17 and ZT21 in non-pregnant and pregnant mice on days 6, 10, 14 and 18. Values are meanGS.E.M. (nZ6-8/group). Gray shading represents the dark phase of the light cycle. For Crh expression, cosinor curves are not shown since this analysis showed no statistical significance at any stage.
For these profiles, values without a common notation differ significantly (P!0.001; two-way ANOVA and post hoc LSD test). For plasma corticosterone and 11-DHC, insets are included for non-pregnant levels and days 6 and 10 of pregnancy to show the same data on a reduced y-axis scale. The best-fit curve derived from cosinor analysis is shown as a solid line when significant (P!0.05) and as a dashed line when non-significant.
with a dramatic decline in levels observed by day 18 (83% lower than non-pregnant levels, Fig. 3B ). Cosinor analysis showed highly significant circadian variation for plasma ACTH on days 6, 10 and 18 of pregnancy (see Table 4 for r 2 and P values). The mesor, amplitude and acrophase for these days of gestation are presented in Table 5 . The mesor levels of plasma ACTH increased 1.3-fold between diestrus and early gestation (days 6 and 10), before decreasing by 43% on day 14 and a further 77% on day 18 (P!0.0001; Fig. 3B ). While the amplitude did not change across pregnancy, the acrophase was delayed w7 h by day 18 of pregnancy (P!0.001; Table 5 ).
Plasma corticosterone
Plasma corticosterone levels varied with time of day (P!0.001, ANOVA), with all profiles characterized by a daily peak soon after lights off at ZT13 (Fig. 3C ). Pregnancy had a dramatic effect on the absolute levels of plasma corticosterone (P!0.001), with overall increases observed between non-pregnant levels and day 14 (11-fold) and day 18 (14-fold) of pregnancy. There was also a significant time of day!stage of pregnancy interaction (P!0.05),
indicating that the circadian variation in plasma corticosterone was influenced by the stage of pregnancy. Cosinor analysis showed highly significant circadian variation for plasma corticosterone on days 6, 10 and 14 of pregnancy (see Table 4 for r 2 and P values). While there was only a trend for cosinor rhythmicity prior to pregnancy, clear time-of-day variation existed within this group (P!0.05, ANOVA) with a 2.3-fold increase in levels between ZT1 and ZT13 (P!0.01, unpaired t-test). Interestingly, rhythmic variation in corticosterone appeared to be lost by day 18, with high levels maintained across the full 24 h period. The derived mesor, amplitude and acrophase for plasma corticosterone at each stage of gestation are presented in Table 5 . The mesor level of plasma corticosterone was similar before and on days 6 and 10 of pregnancy, but had increased by approximately tenfold 4 days later (on day 14; P!0.001) and by another 1.2-fold by day 18 (P!0.001; Fig. 3C ). The amplitude of the corticosterone rhythm displayed a similar pattern (P!0.001), remaining unchanged up to day 10 but then increasing dramatically (almost 20-fold) by day 14 before falling by day 18 (but still 5.5-fold greater than before pregnancy) (Fig. 3C) . The acrophase of the corticosterone rhythm remained unchanged across pregnancy (Fig. 3C) . Relevant P values are shown in parentheses unless non-significant (NS). Plasma levels of the corticosterone metabolite 11-DHC generally paralleled the circadian pattern of corticosterone, varying with time of day (P!0.001, ANOVA) and showing peak levels soon after lights off. Plasma 11-DHC levels also varied with stage of pregnancy (P!0.001; Fig. 3D) , and there was a significant interaction between time of day and stage of pregnancy (P!0.05).
As with plasma corticosterone, cosinor analysis showed highly significant circadian variation for plasma 11-DHC on days 6 and 14 of pregnancy (see Table 4 for r 2 and P values), with a trend for rhythmicity evident on day 10. The mesor level remained relatively stable until day 10 but then increased more than 7-fold by days 14 and 18 (P!0.001; Table 5 , Fig. 3D ). The amplitude of the plasma 11-DHC rhythm increased tenfold between days 6 and 14, but by day 18, rhythmic variation in 11-DHC was effectively absent (Fig. 3D) .
Ratio of corticosterone:11-DHC
The ratio of corticosterone:11-DHC remained relatively stable until day 10 but then increased by day 14 (1.75-fold; PZ0.002), before returning to non-pregnant levels by day 18 (Table 5 , Fig. 4 ).
Correlations between plasma corticosterone and hypothalamic clock genes and plasma ACTH
We also explored possible relationships between clock gene expression and circulating corticosterone (Supplementary Table 1 , see section on supplementary data given at the end of this article). Thus, plasma corticosterone was negatively correlated with hypothalamic Bmal1 (on days 6 and 14 of pregnancy), Clock (on days 6, 10, 14 and 18 of pregnancy) and Cry2 (on day 14 of pregnancy). In contrast, a positive association was observed between plasma corticosterone and Rora (on day 6 of pregnancy). Finally, plasma ACTH was positively correlated with corticosterone only on day 10 of pregnancy.
Discussion
This study demonstrates for the first time that the hypothalamic expression of the core (Clock, Bmal1, Per1, Per2, Cry1 and Cry2) and accessory (Rev-erba and Rora) clock genes changes markedly during pregnancy in the mouse. Our data also characterize substantial shifts in absolute levels and circadian variation of plasma corticosterone and its key metabolite, 11-DHC, after mid-gestation. Importantly, the marked elevation in circulating glucocorticoids was not associated with comparable changes in either hypothalamic Crh mRNA expression or plasma ACTH, suggesting that higher corticosterone levels may be driven by factors beyond the conventional HPA axis (e.g. placental trophic support for the adrenal).
Clock genes are a set of rhythmically expressed transcription factors that drive rhythms in downstream genes directly involved in numerous physiological processes (Reppert & Weaver 2002 , Hastings et al. 2007 . Hypothalamic expression of all clock genes changed with the onset and progression of pregnancy, with clear effects on the mesor of each clock gene (an indicative measure of overall expression) evident by mid-gestation. Specifically, by day 10 of pregnancy, the mesor of each clock gene was elevated above pre-pregnancy levels and, in the majority of cases, expression was highest at this stage (up to 1.5-fold). These increases in clock gene expression suggest a major shift in the function of the central clock in pregnancy, presumably to drive gestational adaptations in maternal behavior and physiology. Together with our previous findings of pregnancy-induced changes to liver clock genes late in rat gestation (Wharfe et al. 2011) , the present data suggest that widespread alterations to the circadian system are a feature of maternal physiological adaptations to pregnancy. Further studies are required to determine the mechanisms by which pregnancy-induced changes in central and peripheral clocks occur, but a role for the highly dynamic hormonal milieu of pregnancy seems likely. Indeed, a number of clock genes contain estrogen and progesterone response elements within their promoter regions (Nakamura et al. 2005 , He et al. 2007 , Nakamura et al. 2010 , and ERa, ERb and PR are expressed within the SCN (Blaustein & Wade 1978 , Blaustein et al. 1988 , Vida et al. 2008 . Previous studies have also shown that clock gene expression is influenced by estradiol in the SCN (Nakamura et al. 2001 , Nakamura et al. 2005 and by progesterone in the uterus (He et al. 2007 , Nakamura et al. 2010 , Rubel et al. 2012 . Moreover, the clock gene expression can be regulated by corticosterone, as glucocorticoid response elements are present within the promoter regions of Per1, Per2 and Rev-erba (Balsalobre et al. 2000 , Yamamoto et al. 2005 , So et al. 2009 ). However, corticosterone is unlikely to drive pregnancy-induced changes in the central clock directly since glucocorticoid receptor expression is absent or minimal within the SCN (Rosenfeld et al. 1988 , Balsalobre et al. 2000 , Kalsbeek et al. 2012 .
In contrast to the changes in the hypothalamic expression of the clock genes, that of Crh remained relatively stable across pregnancy. Similarly, while Crh expression showed a trend for overall time-of-day variation, this did not match the conventional cosinor pattern observed for the clock genes. These observations may appear surprising given that ablation studies (both anatomical and transgenic) have highlighted the importance of the SCN in the regulation of the diurnal secretion of corticosterone (Moore & Eichler 1972 , Sellix et al. 2006 . Interestingly, while a previous study also observed arrhythmic hypothalamic Crh mRNA expression in the mouse, rhythmic expression of Crh heteronuclear (hn) RNA was detected, indicative of circadian variation in Crh at this pre-processing stage (Watts et al. 2004 ). This suggests that hypothalamic Crh expression at the heteronuclear RNA level may be influenced by the rhythmic expression of SCN clock genes, but this is obscured by other regulatory factors at the mRNA level. Moreover, the central clock also appears to influence the HPA axis independently of CRH, possibly via changes in adrenocortical sensitivity to ACTH across the circadian day (Kaneko et al. 1981) . This effect is mediated centrally via the autonomic nervous system (ANS) (Buijs et al. 1999) .
Our data also show for the first time that the full circadian profile of maternal corticosterone increases dramatically after mid-gestation in the mouse (i.e. on days 14 and 18). Elevation of the full circadian profile of glucocorticoids has previously been reported for human (Patrick et al. 1980) and rat pregnancy (Atkinson & Waddell 1995) , but the magnitude of the increase observed here in the mouse is several fold greater.
Moreover, these higher levels of corticosterone occurred even though absolute levels of plasma ACTH fell markedly over the same period. This apparent decoupling of circulating ACTH and corticosterone suggests that factors outside the conventional HPA axis influence plasma corticosterone in pregnancy. For example, enhanced adrenal responsiveness appears to drive increased maternal corticosterone levels after mid-gestation in the rat (Atkinson & Waddell 1995) , an effect likely mediated via rising estrogen levels (Atkinson & Waddell 1997 , Figueiredo et al. 2007 ). Other 'non-HPA axis' factors that could enhance maternal levels of corticosterone include a fall in its metabolic clearance rate due to higher plasma corticosteroid-binding globulin (CBG) levels (Gala & Westphal 1967 , Douglas et al. 2003 or a contribution from the fetal adrenal. The latter is consistent with activation of the fetal HPA axis late in development (Cottrell et al. 2012 ) and the coincident loss of the placental glucocorticoid barrier (Brown et al. 1996) , which may also explain the loss of maternal corticosterone rhythmicity by day 18 of gestation. Finally, a number of studies have suggested that the placenta could provide direct trophic support to the adrenal, thereby stimulating adrenal corticosterone secretion independently of the HPA axis (Waddell 1993 , Waddell & Burton 1993 .
Given the established links between the central clock and adrenal sensitivity (via the ANS) (Buijs et al. 1999) and with the HPA axis (Nader et al. 2010) , one might expect a positive relationship between hypothalamic clock gene expression and corticosterone levels. On the contrary, our data show that there was no such association for the majority of the clock genes, and where a relationship was observed (three of eight genes), it was predominantly negative. The single exception was for Rora, which showed a positive association with corticosterone on day 6 of gestation. Further studies are required to determine whether the multiple regulatory pathways that link the central clock and the adrenal cortex (e.g. via adrenal sensitivity and regulation of clock gene expression indirectly by corticosterone) obscure such correlations.
The biologically inert metabolite of corticosterone, 11-DHC, was detectable in plasma at all stages of pregnancy but at much lower concentrations than corticosterone. For the first time, we have shown that throughout pregnancy, the circadian profiles of 11-DHC generally paralleled the corresponding corticosterone profiles, including the apparent loss of rhythmicity on day 18. The ratio of corticosterone:11-DHC increased substantially on day 14, possibly due to greater plasma CBG binding of corticosterone and an associated reduction in the proportion metabolized to 11-DHC (Barlow et al. 1974 (Barlow et al. , 1975 . This conversion is catalyzed by the 11b-hydroxysteroid dehydrogenase enzymes (11b-HSD1 and 11b-HSD2), and opposite changes in their expression occur in the two placental zones late in rodent pregnancy (Mark et al. 2009 ). These changes in enzyme expression are likely to influence total 11b-HSD enzymatic capacity and thereby impact on the plasma corticosterone:11-DHC ratio near term.
It is possible that alterations to the circadian system during pregnancy, such as those seen in the central clock and the HPA axis, may contribute to gestational adaptations in maternal metabolism. Indeed, the central clock is known to influence peripheral tissue clocks via neural and humoral signals (Hastings et al. 2007) . Furthermore, links between the clock gene network and metabolism (Froy 2010) indicate that changes to circadian rhythms of clock gene expression in peripheral tissues regulate the expression of downstream genes governing physiological processes including glucose and lipid metabolism, both of which are adapted in pregnancy (Suman Rao et al. 2013) . For example, the steady increase in the absolute levels of hypothalamic Bmal1 across gestation may contribute to the sustained availability of nutrients from peripheral tissue stores by driving altered neural and/or humoral signals via the PVN (Kalsbeek et al. 2006) . Previous studies have shown that hepatic Bmal1 is particularly important in relation to the regulation of hepatic glucose metabolism (Lamia et al. 2008) , while Rev-erba plays a key role in lipid metabolism within the liver and adipose tissue (Delezie et al. 2012) . Accordingly, it will be of interest to explore how changes in the central and peripheral circadian clocks influence maternal metabolic adaptations in pregnancy.
In conclusion, this study shows that the central circadian clock undergoes marked adaptations with the onset and progression of mouse pregnancy. Importantly, neither clock genes nor plasma ACTH levels appear to drive the dramatic increase in the maternal glucocorticoid levels observed after mid-gestation. The pregnancyinduced changes in the central circadian clock and the HPA axis likely promote pregnancy success by driving maternal physiological adaptations to meet the metabolic demands of fetal growth.
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